International Medical Center of Biomaterials Processing and Cryostorage (MOEX:GEMA)

MOEX:GEMA Cash Flow Statement

Financials in millions RUB. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	151.22	125.78	98.17	129.17	122.77
Depreciation & Amortization	-	11.24	6.86	4.14	10.41
Other Operating Activities	96.39	86.76	136.07	111.19	4.69
Change in Accounts Receivable	-	-	-	-	-11.99
Change in Inventory	-	-	-	-	-1.07
Change in Accounts Payable	-	-	-	-	19.2
Operating Cash Flow	247.6	223.77	241.11	244.51	134.72
Operating Cash Flow Growth	10.65%	-7.19%	-1.39%	81.49%	19.07%
Capital Expenditures	-11.08	-14.18	-9.27	-4.68	-2.46
Investment in Securities	-	5.5	-99	-506.4	-
Other Investing Activities	21.94	6.54	0.89	32.19	1.17
Investing Cash Flow	-6.53	4.84	-252.87	-77.52	-54.92
Long-Term Debt Issued	-	-	200	-	-
Total Debt Issued	-	-	200	-	-
Long-Term Debt Repaid	-	-	-1.87	-	-
Net Debt Issued (Repaid)	-	-	198.13	-	-
Common Dividends Paid	-153.4	-122.74	-141.06	-150.19	-85.1
Other Financing Activities	-6.88	14.25	-5	-6.02	-4.04
Financing Cash Flow	-160.28	-108.49	52.07	-156.21	-89.14
Foreign Exchange Rate Adjustments	0.03	-0.03	-0.3	-0.01	-0.09
Net Cash Flow	80.83	120.09	40.01	10.76	-9.43
Free Cash Flow	236.53	209.59	231.83	239.82	132.26
Free Cash Flow Growth	12.85%	-9.59%	-3.33%	81.33%	16.90%
Free Cash Flow Margin	67.85%	73.93%	91.03%	90.20%	54.51%
Free Cash Flow Per Share	-	14.04	15.53	16.06	8.86
Cash Interest Paid	-	31.57	3.74	3.52	4.04
Levered Free Cash Flow	99.34	99.84	557.78	-334.44	95.29
Unlevered Free Cash Flow	120.95	120.81	568.79	-332.25	99.57
Change in Working Capital	-	-	-	-	6.14

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.